ReposiTrak, Inc. (TRAK) is a Salt Lake City-based software-as-a-service provider whose AI-powered platform handles food traceability, supplier compliance and risk management, and retail supply chain operations for grocers, wholesalers and food manufacturers. Shares dropped 8.25% to $6.67 in Tuesday's opening session, compared with the prior close of $7.27, a decline of $0.60. The direction is unambiguously negative, and the catalyst is verified: the company reported fiscal first-quarter 2027 results after Monday's close, missing earnings expectations and posting a year-over-year revenue decline alongside margin compression and a strategic pivot toward a lower-margin affiliate.
The fiscal quarter ended September 30 produced revenue of $5.78 million, down 3% from $5.97 million a year earlier, though up roughly $200,000 sequentially. Earnings per share came in at $0.08 basic and diluted versus $0.10 a year ago and against a consensus near $0.10, a shortfall of about 20%.
The quality of the print drew more scrutiny than the headline. Operating income fell 12% to $1.7 million and operating margin narrowed to 28.7% from 31.7%. General and administrative expense rose roughly 11% on higher personnel and benefit costs, while total operating costs edged up 1% after prior periods of aggressive cost cutting. A 68% drop in depreciation and amortization to $77,000 cushioned the reported result — a tailwind that will not repeat. Net income fell 16% to $1.5 million. With no numeric guidance issued, investors were left to weigh a qualitative promise of sequential improvement against a revenue line that has now declined for consecutive quarters.
Management attributed the revenue decline to the FDA's extension of its Food Traceability Rule enforcement date to July 2028, which has pushed customer purchasing decisions into later periods. For a compliance-driven software business, the deadline is the sales pitch; when it moves out more than two years, urgency evaporates. The cost base of roughly $4.1 million per quarter does not move with it. Management said traceability inquiries are rising again, but the revenue consequence now sits in fiscal 2028 and 2029 rather than the next four quarters.
Operating cash flow swung to an outflow of about $445,000 from an inflow of $1.54 million a year earlier, driven by $1.6 million in cash taxes, a $1.09 million receivables build and a $920,000 reduction in accrued liabilities. Cash and equivalents fell to $24.5 million from $27.3 million at June 30, below the roughly $25 million level management had previously referenced. The company repurchased no shares and redeemed no preferred stock during the quarter, prioritizing the SPAR investment, and did not repeat earlier capital-return targets. Notes payable and finance leases rose to about $2.8 million from under $300,000, largely reflecting SPAR shares acquired with a promissory note.
Announced alongside the quarter, the transaction would exchange ReposiTrak's roughly 8.9 million SGRP common shares and convert its $4.0 million note into a new SPAR preferred class at a common-equivalent price near $0.38, with anti-dilution protection, 50% warrant coverage and a new $1.5 million revolver. ReposiTrak would hold about 49.99% of SPAR on an as-converted basis.
The strategic logic — pairing software data with SPAR's in-store field force to power Touchless Retail — is real, and pilot results were strong, with a 17% sales lift at a dairy distributor and nearly 26% in greeting cards against a 5% target. But SPAR's most recent quarter showed net revenue down 19%, an 18.9% gross margin and a 0.7% operating margin. Investors are effectively being asked to accept a blend of 85%-gross-margin software economics with a shrinking, labor-intensive services business, plus rising single-partner concentration.
The decline is company-specific rather than sector-driven; there is no meaningful cluster of directly comparable traceability or compliance-software peers to drag the stock lower, and the move is far larger than anything in the broader market. Volume in the first minutes of the session was minimal, with only a few hundred shares changing hands against a 60-day average near 91,000, so the gap reflects repricing at the open rather than sustained institutional distribution. Technically, the stock gapped below its recent $7.00–$7.35 consolidation range and is pressing against its 52-week low of $6.61, a level that has acted as the floor for a twelve-month decline of roughly 50%. Market capitalization sits near $121 million.
The scale runs from 0 — no meaningful news and a normal move for the stock — to 100, meaning transformative news paired with an extreme, rare price move. ReposiTrak earns 50 out of 100.
The verified news was moderate in strength: an earnings miss, a third consecutive revenue decline, margin compression and a pause in capital returns, all material for a company of this size but short of a transformative event. The price response was genuinely unusual. Today's 8.25% decline is roughly 4.9 times the stock's average absolute daily move of about 1.7% over the past 60 sessions, and no session in that window produced an equal or larger move. Solid news combined with a rare reaction produces a mid-range score rather than an extreme one.
Attention turns to fiscal second-quarter results, where management expects a six-figure Touchless Retail revenue contribution and sequential top-line improvement. Investors will want evidence that the roughly 20 pilots translate into durable rollouts rather than one-off tests. The FDA's 2028 compliance deadline remains the swing factor for the core traceability business, and any acceleration in inquiry conversion would be meaningful. Analysts currently carry a single consensus recommendation with limited coverage depth, so revisions may be sharp. Risks include further core revenue erosion, continued negative cash flow, execution risk on the SPAR recapitalization and the margin dilution it implies, and the possibility that buybacks and preferred redemptions stay suspended longer than expected. The absence of numeric guidance leaves the outlook unusually dependent on management commentary.
Tickeron offers hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market conditions are surfaced in its curated Trending AI Robots section. Bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, so the featured list changes as market conditions evolve. Reviewing that page can help traders see which automated approaches are working right now — and whether any of them fit their own risk parameters.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Aroon Indicator for TRAK entered a downward trend on November 17, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 223 similar instances where the Aroon Indicator formed such a pattern. In 185 of the 223 cases the stock moved lower. This puts the odds of a downward move at 83%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 58 cases where TRAK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TRAK as a result. In 64 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRAK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TRAK's RSI Indicator exited the oversold zone, 14 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 44%.
The Moving Average Convergence Divergence (MACD) for TRAK just turned positive on November 09, 2026. Looking at past instances where TRAK's MACD turned positive, the stock continued to rise in 34 of 45 cases over the following month. The odds of a continued upward trend are 76%.
Following a +7.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRAK advanced for three days, in 212 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
TRAK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Seasonality Score of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.349) is normal, around the industry mean (-1.922). P/E Ratio (16.488) is within average values for comparable stocks, (9.599). Projected Growth (PEG Ratio) (0.140) is also within normal values, averaging (2.824). Dividend Yield (0.012) settles around the average of (0.069) among similar stocks. P/S Ratio (6.693) is also within normal values, averaging (70.699).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. TRAK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of proprietary software products
Industry PackagedSoftware